Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 236 entries
Sorted by: Best Match Show Resources per page
Activation of 5-HT 1b/d receptor restores the cognitive function by reducing glutamate release, deposition of β-amyloid and TLR-4 pathway in the brain of scopolamine-induced dementia in rat.

The Journal of pharmacy and pharmacology

Tripathi AS, Bansod P, Swathi KP.
PMID: 34244776
J Pharm Pharmacol. 2021 Dec 07;73(12):1592-1598. doi: 10.1093/jpp/rgab095.

OBJECTIVES: This study evaluates the effect of 5-HT 1b/d agonist on cognitive function in scopolamine (SPN)-induced dementia in the rat.METHODS: Dementia was induced by administration of SPN 2 mg/kg/day, intraperitoneally, for a duration of 21 days. The effect of...

Cite
Tripathi AS, Bansod P, Swathi KP. Activation of 5-HT 1b/d receptor restores the cognitive function by reducing glutamate release, deposition of β-amyloid and TLR-4 pathway in the brain of scopolamine-induced dementia in rat. J Pharm Pharmacol. 2021;73(12):1592-1598doi: 10.1093/jpp/rgab095.
Tripathi, A. S., Bansod, P., & Swathi, K. P. (2021). Activation of 5-HT 1b/d receptor restores the cognitive function by reducing glutamate release, deposition of β-amyloid and TLR-4 pathway in the brain of scopolamine-induced dementia in rat. The Journal of pharmacy and pharmacology, 73(12), 1592-1598. https://doi.org/10.1093/jpp/rgab095
Tripathi, Alok Shiomurti, et al. "Activation of 5-HT 1b/d receptor restores the cognitive function by reducing glutamate release, deposition of β-amyloid and TLR-4 pathway in the brain of scopolamine-induced dementia in rat." The Journal of pharmacy and pharmacology vol. 73,12 (2021): 1592-1598. doi: https://doi.org/10.1093/jpp/rgab095
Tripathi AS, Bansod P, Swathi KP. Activation of 5-HT 1b/d receptor restores the cognitive function by reducing glutamate release, deposition of β-amyloid and TLR-4 pathway in the brain of scopolamine-induced dementia in rat. J Pharm Pharmacol. 2021 Dec 07;73(12):1592-1598. doi: 10.1093/jpp/rgab095. PMID: 34244776.
Copy Download .nbib Format: NLM
Pharmacokinetics and brain distribution studies of 6-hydroxykynurenic acid and its structural modified compounds.

The Journal of pharmacy and pharmacology

Shen Z, Hu H, Pan J, Xu M, Ou F, He K, Zeng K, Yao J, Wang R, Lou Y, Zeng S.
PMID: 34586411
J Pharm Pharmacol. 2022 Jan 05;74(1):22-31. doi: 10.1093/jpp/rgab132.

OBJECTIVES: 6-Hydroxykynurenic acid (6-HKA) is an organic acid component in extracts of Ginkgo biloba leaves and acts as a major contributor to neurorestorative effects, while its oral bioavailability was low. Therefore, using prodrug method to improve the bioavailability and...

Cite
Shen Z, Hu H, Pan J, et al. Pharmacokinetics and brain distribution studies of 6-hydroxykynurenic acid and its structural modified compounds. J Pharm Pharmacol. 2022;74(1):22-31doi: 10.1093/jpp/rgab132.
Shen, Z., Hu, H., Pan, J., Xu, M., Ou, F., He, K., Zeng, K., Yao, J., Wang, R., Lou, Y., & Zeng, S. (2022). Pharmacokinetics and brain distribution studies of 6-hydroxykynurenic acid and its structural modified compounds. The Journal of pharmacy and pharmacology, 74(1), 22-31. https://doi.org/10.1093/jpp/rgab132
Shen, Zhuowei, et al. "Pharmacokinetics and brain distribution studies of 6-hydroxykynurenic acid and its structural modified compounds." The Journal of pharmacy and pharmacology vol. 74,1 (2022): 22-31. doi: https://doi.org/10.1093/jpp/rgab132
Shen Z, Hu H, Pan J, Xu M, Ou F, He K, Zeng K, Yao J, Wang R, Lou Y, Zeng S. Pharmacokinetics and brain distribution studies of 6-hydroxykynurenic acid and its structural modified compounds. J Pharm Pharmacol. 2022 Jan 05;74(1):22-31. doi: 10.1093/jpp/rgab132. PMID: 34586411.
Copy Download .nbib Format: NLM
Corrigendum to: Remimazolam alleviates neuropathic pain via regulating bradykinin receptor B1 and autophagy.

The Journal of pharmacy and pharmacology

Xie H, Lu F, Liu W, Wang E, Wang L, Zhong M.
PMID: 34190314
J Pharm Pharmacol. 2021 Jun 30; doi: 10.1093/jpp/rgab101. Epub 2021 Jun 30.

No abstract available.

Cite
Xie H, Lu F, Liu W, et al. Corrigendum to: Remimazolam alleviates neuropathic pain via regulating bradykinin receptor B1 and autophagy. J Pharm Pharmacol. 2021;doi: 10.1093/jpp/rgab101.
Xie, H., Lu, F., Liu, W., Wang, E., Wang, L., & Zhong, M. (2021). Corrigendum to: Remimazolam alleviates neuropathic pain via regulating bradykinin receptor B1 and autophagy. The Journal of pharmacy and pharmacology, . https://doi.org/10.1093/jpp/rgab101
Xie, Haiyu, et al. "Corrigendum to: Remimazolam alleviates neuropathic pain via regulating bradykinin receptor B1 and autophagy." The Journal of pharmacy and pharmacology vol. (2021). doi: https://doi.org/10.1093/jpp/rgab101
Xie H, Lu F, Liu W, Wang E, Wang L, Zhong M. Corrigendum to: Remimazolam alleviates neuropathic pain via regulating bradykinin receptor B1 and autophagy. J Pharm Pharmacol. 2021 Jun 30; doi: 10.1093/jpp/rgab101. Epub 2021 Jun 30. PMID: 34190314.
Copy Download .nbib Format: NLM
The potential protective effect of the Polygonum hydropiper L against the development of fructose-induced oxidative stress and metabolic disorders in male Sprague-Dawely rats.

The Journal of pharmacy and pharmacology

Batool A, Saleem M, Alamgeer, Mushtaq MN, Alotaibi NH, Alharbi KS, Bukhari SNA.
PMID: 34165561
J Pharm Pharmacol. 2021 Jun 22; doi: 10.1093/jpp/rgab071. Epub 2021 Jun 22.

OBJECTIVES: Polygnum hydropiper L (Polygonaceae) is commonly known as smart weed. This study was designed to assess the effect of aqueous methanolic extract of P. hydropiper on oxidative stress and metabolic changes in fructose-induced hypertensive rats.METHODS: Male Sprague-Dawely rats...

Cite
Batool A, Saleem M, Alamgeer, et al. The potential protective effect of the Polygonum hydropiper L against the development of fructose-induced oxidative stress and metabolic disorders in male Sprague-Dawely rats. J Pharm Pharmacol. 2021;doi: 10.1093/jpp/rgab071.
Batool, A., Saleem, M., Alamgeer, Mushtaq, M. N., Alotaibi, N. H., Alharbi, K. S., & Bukhari, S. N. A. (2021). The potential protective effect of the Polygonum hydropiper L against the development of fructose-induced oxidative stress and metabolic disorders in male Sprague-Dawely rats. The Journal of pharmacy and pharmacology, . https://doi.org/10.1093/jpp/rgab071
Batool, Amna, et al. "The potential protective effect of the Polygonum hydropiper L against the development of fructose-induced oxidative stress and metabolic disorders in male Sprague-Dawely rats." The Journal of pharmacy and pharmacology vol. (2021). doi: https://doi.org/10.1093/jpp/rgab071
Batool A, Saleem M, Alamgeer, Mushtaq MN, Alotaibi NH, Alharbi KS, Bukhari SNA. The potential protective effect of the Polygonum hydropiper L against the development of fructose-induced oxidative stress and metabolic disorders in male Sprague-Dawely rats. J Pharm Pharmacol. 2021 Jun 22; doi: 10.1093/jpp/rgab071. Epub 2021 Jun 22. PMID: 34165561.
Copy Download .nbib Format: NLM
An in-vitro comparative study of the binding of caspofungin and micafungin to plasma proteins.

The Journal of pharmacy and pharmacology

Yamasaki K, Sakurama K, Nishi K, Tsukigawa K, Seo H, Otagiri M, Taguchi K.
PMID: 34791369
J Pharm Pharmacol. 2021 Nov 16; doi: 10.1093/jpp/rgab157. Epub 2021 Nov 16.

OBJECTIVES: Echinocandins are widely used for the treatment of invasive fungal diseases. While they bind strongly to plasma proteins, our knowledge of this process is not sufficient to permit their pharmacokinetics and pharmacodynamics targets to be discussed. In this...

Cite
Yamasaki K, Sakurama K, Nishi K, et al. An in-vitro comparative study of the binding of caspofungin and micafungin to plasma proteins. J Pharm Pharmacol. 2021;doi: 10.1093/jpp/rgab157.
Yamasaki, K., Sakurama, K., Nishi, K., Tsukigawa, K., Seo, H., Otagiri, M., & Taguchi, K. (2021). An in-vitro comparative study of the binding of caspofungin and micafungin to plasma proteins. The Journal of pharmacy and pharmacology, . https://doi.org/10.1093/jpp/rgab157
Yamasaki, Keishi, et al. "An in-vitro comparative study of the binding of caspofungin and micafungin to plasma proteins." The Journal of pharmacy and pharmacology vol. (2021). doi: https://doi.org/10.1093/jpp/rgab157
Yamasaki K, Sakurama K, Nishi K, Tsukigawa K, Seo H, Otagiri M, Taguchi K. An in-vitro comparative study of the binding of caspofungin and micafungin to plasma proteins. J Pharm Pharmacol. 2021 Nov 16; doi: 10.1093/jpp/rgab157. Epub 2021 Nov 16. PMID: 34791369.
Copy Download .nbib Format: NLM
The relationship of telmisartan with sclerostin in the osteoporosis model induced by ovariectomy in rats.

The Journal of pharmacy and pharmacology

Kutlu Z, Bilen A, Celik M, Maman A, Gulaboglu M, Kul A, Celik Z, Halici Z.
PMID: 34874446
J Pharm Pharmacol. 2021 Dec 07;73(12):1693-1702. doi: 10.1093/jpp/rgab123.

OBJECTIVES: Our aim is to explain the relationship between Ang II and Scl in osteoporotic (OP) rats and the contribution of Scl in the antiosteoporotic effect mechanism of angiotensin receptor blockers (ARB).METHODS: This study consists of two sub-studies conducted...

Cite
Kutlu Z, Bilen A, Celik M, et al. The relationship of telmisartan with sclerostin in the osteoporosis model induced by ovariectomy in rats. J Pharm Pharmacol. 2021;73(12):1693-1702doi: 10.1093/jpp/rgab123.
Kutlu, Z., Bilen, A., Celik, M., Maman, A., Gulaboglu, M., Kul, A., Celik, Z., & Halici, Z. (2021). The relationship of telmisartan with sclerostin in the osteoporosis model induced by ovariectomy in rats. The Journal of pharmacy and pharmacology, 73(12), 1693-1702. https://doi.org/10.1093/jpp/rgab123
Kutlu, Zerrin, et al. "The relationship of telmisartan with sclerostin in the osteoporosis model induced by ovariectomy in rats." The Journal of pharmacy and pharmacology vol. 73,12 (2021): 1693-1702. doi: https://doi.org/10.1093/jpp/rgab123
Kutlu Z, Bilen A, Celik M, Maman A, Gulaboglu M, Kul A, Celik Z, Halici Z. The relationship of telmisartan with sclerostin in the osteoporosis model induced by ovariectomy in rats. J Pharm Pharmacol. 2021 Dec 07;73(12):1693-1702. doi: 10.1093/jpp/rgab123. PMID: 34874446.
Copy Download .nbib Format: NLM
HDAC9 exacerbates myocardial infarction via inactivating Nrf2 pathways.

The Journal of pharmacy and pharmacology

Liu F, Di Y, Ma W, Kang X, Li X, Ji Z.
PMID: 33963859
J Pharm Pharmacol. 2021 May 08; doi: 10.1093/jpp/rgab065. Epub 2021 May 08.

OBJECTIVES: Myocardial infarction (MI) is the leading cause of death worldwide. Histone deacetylases (HDACs) collectively participate in the initiation and progression of heart diseases, including MI. This study aimed to investigate the roles of histone deacetylase 9 (HDAC9) in...

Cite
Liu F, Di Y, Ma W, et al. HDAC9 exacerbates myocardial infarction via inactivating Nrf2 pathways. J Pharm Pharmacol. 2021;doi: 10.1093/jpp/rgab065.
Liu, F., Di, Y., Ma, W., Kang, X., Li, X., & Ji, Z. (2021). HDAC9 exacerbates myocardial infarction via inactivating Nrf2 pathways. The Journal of pharmacy and pharmacology, . https://doi.org/10.1093/jpp/rgab065
Liu, Fan, et al. "HDAC9 exacerbates myocardial infarction via inactivating Nrf2 pathways." The Journal of pharmacy and pharmacology vol. (2021). doi: https://doi.org/10.1093/jpp/rgab065
Liu F, Di Y, Ma W, Kang X, Li X, Ji Z. HDAC9 exacerbates myocardial infarction via inactivating Nrf2 pathways. J Pharm Pharmacol. 2021 May 08; doi: 10.1093/jpp/rgab065. Epub 2021 May 08. PMID: 33963859.
Copy Download .nbib Format: NLM
The Protective Effect of Natural Compounds on Doxorubicin-Induced Cardiotoxicity via Nicotinamide Adenine Dinucleotide Phosphate Oxidase Inhibition.

The Journal of pharmacy and pharmacology

Yousefian M, Hosseinzadeh H, Hayes AW, Hadizadeh F, Karimi G.
PMID: 34562089
J Pharm Pharmacol. 2021 Sep 25; doi: 10.1093/jpp/rgab109. Epub 2021 Sep 25.

OBJECTIVES: Doxorubicin (DOX) is widely prescribed for the treatment of several human cancers. Unfortunately, cumulative doses of DOX are the main cause of myocardial dysfunction. Although preclinical and pharmaceutical studies were performed to investigate the potential of natural compounds...

Cite
Yousefian M, Hosseinzadeh H, Hayes AW, et al. The Protective Effect of Natural Compounds on Doxorubicin-Induced Cardiotoxicity via Nicotinamide Adenine Dinucleotide Phosphate Oxidase Inhibition. J Pharm Pharmacol. 2021;doi: 10.1093/jpp/rgab109.
Yousefian, M., Hosseinzadeh, H., Hayes, A. W., Hadizadeh, F., & Karimi, G. (2021). The Protective Effect of Natural Compounds on Doxorubicin-Induced Cardiotoxicity via Nicotinamide Adenine Dinucleotide Phosphate Oxidase Inhibition. The Journal of pharmacy and pharmacology, . https://doi.org/10.1093/jpp/rgab109
Yousefian, Mozhdeh, et al. "The Protective Effect of Natural Compounds on Doxorubicin-Induced Cardiotoxicity via Nicotinamide Adenine Dinucleotide Phosphate Oxidase Inhibition." The Journal of pharmacy and pharmacology vol. (2021). doi: https://doi.org/10.1093/jpp/rgab109
Yousefian M, Hosseinzadeh H, Hayes AW, Hadizadeh F, Karimi G. The Protective Effect of Natural Compounds on Doxorubicin-Induced Cardiotoxicity via Nicotinamide Adenine Dinucleotide Phosphate Oxidase Inhibition. J Pharm Pharmacol. 2021 Sep 25; doi: 10.1093/jpp/rgab109. Epub 2021 Sep 25. PMID: 34562089.
Copy Download .nbib Format: NLM
Synthesis of 3,3-dimethyl-6-oxopyrano[3,4-c]pyridines and their antiplatelet and vasodilatory activity.

The Journal of pharmacy and pharmacology

Sirakanyan SN, Hrubša M, Spinelli D, Dias P, Kartsev V, Carazo A, Hovakimyan AA, Pourová J, Hakobyan EK, Karlíčková J, Parvin S, Fadraersada J, Macáková K, Geronikaki A, Mladěnka P.
PMID: 34106261
J Pharm Pharmacol. 2021 Jun 09; doi: 10.1093/jpp/rgab075. Epub 2021 Jun 09.

OBJECTIVES: Both pyridine and pyrano derivatives have been previously shown to possess biologically relevant activity. In this study, we report the incorporation of these two scaffolds into one molecule.METHODS: The designed 3,3-dimethyl-6-oxopyrano[3,4-c]pyridines were synthesized by the acylation of enamine...

Cite
Sirakanyan SN, Hrubša M, Spinelli D, et al. Synthesis of 3,3-dimethyl-6-oxopyrano[3,4-c]pyridines and their antiplatelet and vasodilatory activity. J Pharm Pharmacol. 2021;doi: 10.1093/jpp/rgab075.
Sirakanyan, S. N., Hrubša, M., Spinelli, D., Dias, P., Kartsev, V., Carazo, A., Hovakimyan, A. A., Pourová, J., Hakobyan, E. K., Karlíčková, J., Parvin, S., Fadraersada, J., Macáková, K., Geronikaki, A., & Mladěnka, P. (2021). Synthesis of 3,3-dimethyl-6-oxopyrano[3,4-c]pyridines and their antiplatelet and vasodilatory activity. The Journal of pharmacy and pharmacology, . https://doi.org/10.1093/jpp/rgab075
Sirakanyan, Samvel N, et al. "Synthesis of 3,3-dimethyl-6-oxopyrano[3,4-c]pyridines and their antiplatelet and vasodilatory activity." The Journal of pharmacy and pharmacology vol. (2021). doi: https://doi.org/10.1093/jpp/rgab075
Sirakanyan SN, Hrubša M, Spinelli D, Dias P, Kartsev V, Carazo A, Hovakimyan AA, Pourová J, Hakobyan EK, Karlíčková J, Parvin S, Fadraersada J, Macáková K, Geronikaki A, Mladěnka P. Synthesis of 3,3-dimethyl-6-oxopyrano[3,4-c]pyridines and their antiplatelet and vasodilatory activity. J Pharm Pharmacol. 2021 Jun 09; doi: 10.1093/jpp/rgab075. Epub 2021 Jun 09. PMID: 34106261.
Copy Download .nbib Format: NLM
Corrigendum to: Magnesium isoglycyrrhizinate prevents cadmium-induced activation of JNK and apoptotic hepatocyte death by reversing ROS-inactivated PP2A.

The Journal of pharmacy and pharmacology

Chen X, Wang X, Yang L, Xu H, Wu Y, Wu J, Chen L, Xu C.
PMID: 34718703
J Pharm Pharmacol. 2021 Dec 07;73(12):1726. doi: 10.1093/jpp/rgab149.

No abstract available.

Cite
Chen X, Wang X, Yang L, et al. Corrigendum to: Magnesium isoglycyrrhizinate prevents cadmium-induced activation of JNK and apoptotic hepatocyte death by reversing ROS-inactivated PP2A. J Pharm Pharmacol. 2021;73(12):1726doi: 10.1093/jpp/rgab149.
Chen, X., Wang, X., Yang, L., Xu, H., Wu, Y., Wu, J., Chen, L., & Xu, C. (2021). Corrigendum to: Magnesium isoglycyrrhizinate prevents cadmium-induced activation of JNK and apoptotic hepatocyte death by reversing ROS-inactivated PP2A. The Journal of pharmacy and pharmacology, 73(12), 1726. https://doi.org/10.1093/jpp/rgab149
Chen, Xiaoling, et al. "Corrigendum to: Magnesium isoglycyrrhizinate prevents cadmium-induced activation of JNK and apoptotic hepatocyte death by reversing ROS-inactivated PP2A." The Journal of pharmacy and pharmacology vol. 73,12 (2021): 1726. doi: https://doi.org/10.1093/jpp/rgab149
Chen X, Wang X, Yang L, Xu H, Wu Y, Wu J, Chen L, Xu C. Corrigendum to: Magnesium isoglycyrrhizinate prevents cadmium-induced activation of JNK and apoptotic hepatocyte death by reversing ROS-inactivated PP2A. J Pharm Pharmacol. 2021 Dec 07;73(12):1726. doi: 10.1093/jpp/rgab149. PMID: 34718703.
Copy Download .nbib Format: NLM
Development of 3D printed drug-eluting contact lenses.

The Journal of pharmacy and pharmacology

Mohamdeen YMG, Tabriz AG, Tighsazzadeh M, Nandi U, Khalaj R, Andreadis I, Boateng JS, Douroumis D.
PMID: 34928372
J Pharm Pharmacol. 2021 Dec 20; doi: 10.1093/jpp/rgab173. Epub 2021 Dec 20.

OBJECTIVES: The aim of the work was to introduce 3D printing technology for the design and fabrication of drug-eluting contact lenses (DECL) for the treatment of glaucoma. The development of 3D printed lenses can effectively overcome drawbacks of existing...

Cite
Mohamdeen YMG, Tabriz AG, Tighsazzadeh M, et al. Development of 3D printed drug-eluting contact lenses. J Pharm Pharmacol. 2021;doi: 10.1093/jpp/rgab173.
Mohamdeen, Y. M. G., Tabriz, A. G., Tighsazzadeh, M., Nandi, U., Khalaj, R., Andreadis, I., Boateng, J. S., & Douroumis, D. (2021). Development of 3D printed drug-eluting contact lenses. The Journal of pharmacy and pharmacology, . https://doi.org/10.1093/jpp/rgab173
Mohamdeen, Youssra Moustafa Gadelkareem, et al. "Development of 3D printed drug-eluting contact lenses." The Journal of pharmacy and pharmacology vol. (2021). doi: https://doi.org/10.1093/jpp/rgab173
Mohamdeen YMG, Tabriz AG, Tighsazzadeh M, Nandi U, Khalaj R, Andreadis I, Boateng JS, Douroumis D. Development of 3D printed drug-eluting contact lenses. J Pharm Pharmacol. 2021 Dec 20; doi: 10.1093/jpp/rgab173. Epub 2021 Dec 20. PMID: 34928372.
Copy Download .nbib Format: NLM
Comparative beneficial effects of nebivolol and nebivolol/valsartan combination against mitochondrial dysfunction in angiotensin II-induced pathology in H9c2 cardiomyoblasts.

The Journal of pharmacy and pharmacology

Gul R, Alsalman N, Bazighifan A, Alfadda AA.
PMID: 34453839
J Pharm Pharmacol. 2021 Oct 07;73(11):1520-1529. doi: 10.1093/jpp/rgab124.

OBJECTIVES: Considering the complementary nature of signalling mechanisms and the therapeutic effects of nebivolol, a β1-adrenoreceptor antagonist, and valsartan, an angiotensin receptor blocker (ARB), here we aimed to investigate whether nebivolol/valsartan combination would complement the cardioprotective effects of nebivolol...

Cite
Gul R, Alsalman N, Bazighifan A, et al. Comparative beneficial effects of nebivolol and nebivolol/valsartan combination against mitochondrial dysfunction in angiotensin II-induced pathology in H9c2 cardiomyoblasts. J Pharm Pharmacol. 2021;73(11):1520-1529doi: 10.1093/jpp/rgab124.
Gul, R., Alsalman, N., Bazighifan, A., & Alfadda, A. A. (2021). Comparative beneficial effects of nebivolol and nebivolol/valsartan combination against mitochondrial dysfunction in angiotensin II-induced pathology in H9c2 cardiomyoblasts. The Journal of pharmacy and pharmacology, 73(11), 1520-1529. https://doi.org/10.1093/jpp/rgab124
Gul, Rukhsana, et al. "Comparative beneficial effects of nebivolol and nebivolol/valsartan combination against mitochondrial dysfunction in angiotensin II-induced pathology in H9c2 cardiomyoblasts." The Journal of pharmacy and pharmacology vol. 73,11 (2021): 1520-1529. doi: https://doi.org/10.1093/jpp/rgab124
Gul R, Alsalman N, Bazighifan A, Alfadda AA. Comparative beneficial effects of nebivolol and nebivolol/valsartan combination against mitochondrial dysfunction in angiotensin II-induced pathology in H9c2 cardiomyoblasts. J Pharm Pharmacol. 2021 Oct 07;73(11):1520-1529. doi: 10.1093/jpp/rgab124. PMID: 34453839.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 236 entries